Theodore E Warkentin. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Anticoagulants/adverse effectsAnticoagulants/therapeutic useHeparin/adverse effectsHeparin/analogs & derivativesHeparin/therapeutic useHeparin, Low-Molecular-Weight/adverse effectsHeparin, Low-Molecular-Weight/therapeutic useHumansPrevalencePulmonary Embolism/complicationsPulmonary Embolism/drug therapyThrombocytopenia/chemically inducedThrombocytopenia/epidemiologyVenous Thrombosis/complicationsVenous Thrombosis/drug therapy
Substances: See more » AnticoagulantsHeparin, Low-Molecular-WeightITF 300Heparin
Year: 2006 PMID: 16963651 DOI: 10.1378/chest.130.3.631
Source DB: PubMed Journal: Chest ISSN: 0012-3692 Impact factor: 9.410